Silver Spring, Maryland–(ENEWSPF)–May 2, 2011. The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose control in adults with Type 2 diabetes.
FDA Approves New Treatment for Type 2 Diabetes
More in Health and Fitness:
